Innvotek Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer operating since 2000 with strong ophthalmology, gynaecology and orthopaedic portfolios.
Innvotek Pharmaceuticals products in Pakistan
Innvotek Pharmaceuticals has 54 medicine presentations registered in Pakistan under 41 brands, covering 37 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Ophthalmology. Its brands with the most registered strengths and packs are Invoflox (Ciprofloxacin), Bisoren (Bisoprolol fumarate), Chime (Clarithromycin) and Duzest (Fluoxetine). 54 products have an official DRAP price on MedInfoBase. See all 41 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Innvotek Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 35, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
- Website
- innvotekpharma.com ↗
- Phone
- +92 51 8742223; +92 51 8742224
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Innvotek Pharmaceuticals is priced against the market
50 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Abxicam-20 Dispersible TabletRegistry verified | Piroxicam | — | — | — | 026951Official source ↗ | No indexed price | — | — |
| Acivir Eye ointment | Aciclovir | 3 % | Ointment | 4.5gm | 082035 | PKR 321.23 | PKR 71.38/g | No comparator |
| Am-Invo | Artemether | 20 mg | Tablet | 16's | 079983 | PKR 604.35 | PKR 37.77/tablet | 🔒 Pharma Pro |
| Arexel DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 10's | 094211 | PKR 585.53 | PKR 58.55/tablet | 🔒 Pharma Pro |
| Arexel Forte 80/480 | Artemether | 80 mg | Tablet | 6's | 094210 | PKR 623.31 | PKR 103.89/tablet | 🔒 Pharma Pro |
| Bisoren | Bisoprolol fumarate | 2.5 mg | Tablet | 14's | 106403 | PKR 41.31 | PKR 2.95/tablet | 🔒 Pharma Pro |
| Bisoren | Bisoprolol fumarate | 5 mg | Tablet | 20's | 106404 | PKR 178.75 | PKR 8.94/tablet | 🔒 Pharma Pro |
| Bisoren | Bisoprolol fumarate | 10 mg | Tablet | 20's | 106405 | PKR 321.76 | PKR 16.09/tablet | 🔒 Pharma Pro |
| Bromycin Eye dropsRegistry verified | Tobramycin | — | — | — | 026961Official source ↗ | No indexed price | — | — |
| Bromycin-D Eye DropsRegistry verified | Dexamethasone, Tobramycin | — | — | — | 026960Official source ↗ | No indexed price | — | — |
| CAI | Acetazolamide | 250 mg | Tablet | 30's | 089623 | PKR 313.18 | PKR 10.44/tablet | 🔒 Pharma Pro |
| Cardocap | Clopidogrel | 75 mg | Tablet | 10's | 040556 | PKR 254.96 | PKR 25.50/tablet | 🔒 Pharma Pro |
| Chime | Clarithromycin | 250 mg | Tablet | 10's | 040189 | PKR 462.75 | PKR 46.28/tablet | 🔒 Pharma Pro |
| Chime | Clarithromycin | 500 mg | Tablet | 10's | 040190 | PKR 840.42 | PKR 84.04/tablet | 🔒 Pharma Pro |
| Duzest | Fluoxetine | 10 mg | Tablet | 10's | 094214 | PKR 75.55 | PKR 7.56/tablet | 🔒 Pharma Pro |
| Duzest | Fluoxetine | 20 mg | Tablet | 10's | 094215 | PKR 120.25 | PKR 12.03/tablet | 🔒 Pharma Pro |
| Fluin | Fluconazole | 150 mg | Capsule | 1's | 072283 | PKR 282.37 | PKR 282.37/capsule | 🔒 Pharma Pro |
| Genek | Gentamicin | 0.3 % | Ophthalmic drops | 7.5ml | 026953 | PKR 43.63 | PKR 5.82/mL | 🔒 Pharma Pro |
| Incot | Sulfamethoxazole | 400 mg | Tablet | 40x10's | 052745 | PKR 924.98 | PKR 2.31/tablet | 🔒 Pharma Pro |
| Incot DS | Sulfamethoxazole + Trimethoprim | 400 mg + 160 mg | Tablet | 10x10's | 052746 | PKR 354.42 | PKR 3.54/tablet | No comparator |
| Infolx | Iron polymaltose complex + Folic acid | 100 mg + 0.35 mg | Tablet | 30's | 098177 | PKR 445.76 | PKR 14.86/tablet | 🔒 Pharma Pro |
| Inmox | Moxifloxacin | 400 mg | Tablet | 5's | 079984 | PKR 904.37 | PKR 180.87/tablet | 🔒 Pharma Pro |
| Invofen | Clomifene citrate | 50 mg | Tablet | 10's | 098178 | PKR 399.62 | PKR 39.96/tablet | 🔒 Pharma Pro |
| Invoflox | Ciprofloxacin | 3 mg/mL | Ophthalmic drops | 5ml | 026952 | PKR 183.90 | PKR 36.78/mL | 🔒 Pharma Pro |
| Invoflox | Ciprofloxacin | 250 mg | Tablet | 10's | 096628 | PKR 240.52 | PKR 24.05/tablet | 🔒 Pharma Pro |
| Invoflox | Ciprofloxacin | 500 mg | Tablet | 10's | 096629 | PKR 397.76 | PKR 39.78/tablet | 🔒 Pharma Pro |
| Invoflox | Ciprofloxacin | 750 mg | Tablet | 10's | 096630 | PKR 434.43 | PKR 43.44/tablet | 🔒 Pharma Pro |
| Involine | Linezolid | 400 mg | Tablet | 12's | 106399 | PKR 2,087.85 | PKR 173.99/tablet | 🔒 Pharma Pro |
| Involine | Linezolid | 600 mg | Tablet | 12's | 106400 | PKR 3,655.17 | PKR 304.60/tablet | 🔒 Pharma Pro |
| Invomet | Metformin | 500 mg | Tablet | 50's | 099260 | PKR 117.23 | PKR 2.34/tablet | 🔒 Pharma Pro |
| Itrotek | Itraconazole | 100 mg | Capsule | 4's | 072284 | PKR 583.14 | PKR 145.79/capsule | 🔒 Pharma Pro |
| Letase | Letrozole | 2.5 mg | Tablet | 10's | 087374 | PKR 4,092.78 | PKR 409.28/tablet | 🔒 Pharma Pro |
| Letase | Letrozole | 2.5 mg | Tablet | 30's | 087374 | PKR 12,278.35 | PKR 409.28/tablet | 🔒 Pharma Pro |
| Levee | Levofloxacin | 250 mg | Tablet | 10's | 040191 | PKR 472.14 | PKR 47.21/tablet | 🔒 Pharma Pro |
| Levee | Levofloxacin | 500 mg | Tablet | 10's | 040192 | PKR 785.65 | PKR 78.57/tablet | 🔒 Pharma Pro |
| Midox | Doxycycline | 100 mg | Capsule | 80's | 106398 | PKR 446.17 | PKR 5.58/capsule | 🔒 Pharma Pro |
| Midox | Doxycycline | 100 mg | Capsule | 100's | 106398 | PKR 557.71 | PKR 5.58/capsule | 🔒 Pharma Pro |
| Miltefo | Miltefosine | 50 mg | Capsule | 8x7's | 079407 | PKR 30,217.39 | PKR 539.60/capsule | 🔒 Pharma Pro |
| Misabon | Misoprostol | 200 mcg | Tablet | 10's | 106406 | PKR 143.00 | PKR 14.30/tablet | 🔒 Pharma Pro |
| Misabon | Misoprostol | 200 mcg | Tablet | 28's | 106406 | PKR 400.41 | PKR 14.30/tablet | 🔒 Pharma Pro |
| Mydropic | Tropicamide | 1 % | Ophthalmic drops | 15ml | 024192 | PKR 212.76 | PKR 14.18/mL | 🔒 Pharma Pro |
| Oflotek | Ofloxacin | 0.3 % | Ophthalmic drops | 5ml | 086126 | PKR 148.01 | PKR 29.60/mL | 🔒 Pharma Pro |
| OND 4 | Ondansetron | 4 mg | Tablet | 10's | 102512 | PKR 789.55 | PKR 78.96/tablet | 🔒 Pharma Pro |
| OND 8 | Ondansetron | 8 mg | Tablet | 10's | 102513 | PKR 1,315.92 | PKR 131.59/tablet | 🔒 Pharma Pro |
| Parex 500 | Mebendazole | 100 mg | Tablet | 1's | 026949 | PKR 30.22 | PKR 30.22/tablet | 🔒 Pharma Pro |
| Prednitek | Prednisolone | 1 % | Ophthalmic drops | 5ml | 026963 | PKR 106.85 | PKR 21.37/mL | No comparator |
| Ribavin | Ribavirin | 500 mg | Tablet | 10's | 081634 | PKR 192.81 | PKR 19.28/tablet | 🔒 Pharma Pro |
| Scurvex | Ascorbic acid | 500 mg | Tablet | 40's | 108201 | PKR 41.31 | PKR 1.03/tablet | 🔒 Pharma Pro |
| Semesta | Simvastatin | 10 mg | Tablet | 10's | 040555 | PKR 302.18 | PKR 30.22/tablet | 🔒 Pharma Pro |
| Tesipril H 20+12.5 | Lisinopril + Hydrochlorothiazide | 20 mg + 12.5 mg | Tablet | 28's | 095572 | PKR 849.97 | PKR 30.36/tablet | 🔒 Pharma Pro |
All 41 Innvotek Pharmaceuticals brands in Pakistan
- Acivir Eye ointment Aciclovir · 3 % ointment
- Am-Invo Artemether · 20 mg tablet
- Arexel DS Artemether + Lumefantrine · 40 mg + 240 mg tablet
- Arexel Forte 80/480 Artemether · 80 mg tablet
- Bisoren Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- CAI Acetazolamide · 250 mg tablet
- Cardocap Clopidogrel · 75 mg tablet
- Chime Clarithromycin · 250 mg tablet, 500 mg tablet
- Duzest Fluoxetine · 10 mg tablet, 20 mg tablet
- Fluin Fluconazole · 150 mg capsule
- Genek Gentamicin · 0.3 % drops
- Incot Sulfamethoxazole · 400 mg tablet
- Incot DS Sulfamethoxazole + Trimethoprim · 400 mg + 160 mg tablet
- Infolx Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
- Inmox Moxifloxacin · 400 mg tablet
- Invofen Clomifene citrate · 50 mg tablet
- Invoflox Ciprofloxacin · 250 mg tablet, 3 mg/mL drops, 500 mg tablet
- Involine Linezolid · 400 mg tablet, 600 mg tablet
- Invomet Metformin · 500 mg tablet
- Itrotek Itraconazole · 100 mg capsule
- Letase Letrozole · 2.5 mg tablet
- Levee Levofloxacin · 250 mg tablet, 500 mg tablet
- Midox Doxycycline · 100 mg capsule
- Miltefo Miltefosine · 50 mg capsule
- Misabon Misoprostol · 200 mcg tablet
- Mydropic Tropicamide · 1 % drops
- Oflotek Ofloxacin · 0.3 % drops
- OND 4 Ondansetron · 4 mg tablet
- OND 8 Ondansetron · 8 mg tablet
- Parex 500 Mebendazole · 100 mg tablet
- Prednitek Prednisolone · 1 % drops
- Ribavin Ribavirin · 500 mg tablet
- Scurvex Ascorbic acid · 500 mg tablet
- Semesta Simvastatin · 10 mg tablet
- Tesipril H 20+12.5 Lisinopril + Hydrochlorothiazide · 20 mg + 12.5 mg tablet
- Timotek Timolol · 0.5 % drops
- Viraday Tenofovir disoproxil · 300 mg tablet
- Xalanol Eyes 2.5 ml Latanoprost · 0.005 % drops
- Xalanol-T Latanoprost · 50 mcg/mL drops
- Zesty 250 Azithromycin · 250 mg tablet
- Zesty 500 Azithromycin · 500 mg tablet
Innvotek Pharmaceuticals: common questions
How many products does Innvotek Pharmaceuticals have in Pakistan?
Innvotek Pharmaceuticals has 54 registered medicine presentations in Pakistan, sold under 41 brands and covering 37 generic medicines.
What are the main brands of Innvotek Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Invoflox (Ciprofloxacin), Bisoren (Bisoprolol fumarate), Chime (Clarithromycin), Duzest (Fluoxetine) and Involine (Linezolid). This is not a sales ranking.
Which therapy areas does Innvotek Pharmaceuticals cover?
The most products are in Anti-infectives (30), Cardiovascular (5), Ophthalmology (5), Reproductive & genitourinary (3) and CNS & mental health (2).
Where can I see Innvotek Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.